EUVIMEDEUVIMED entdecken
CrossrefInfokarte

The Evolving Therapeutics of Endothelial Disease

Marcela Huertas-Bello, Alfonso L. Sabater, Ellen H. Koo

Eye Banking and Corneal Transplantation · 2023

DOI: 10.1097/ebct.0000000000000015 ↗
AbstractBibliografische Angaben

Abstract

Abstract: Endothelial dysfunction is one of the leading indications for corneal transplantation. Globally, there is a shortage of donor corneas, which is partly because of the lack of eye banking resources in emerging countries. Given this global shortage, there is naturally heightened interest surrounding pharmacological agents, genetic therapy, and endothelial cell–based therapeutic modalities. Endothelial cells have limited mitotic capacity in vivo, and thus, studies have been conducted for their ex vivo expansion using mitogens. Similarly, pluripotent stem cells have been used to differentiate into human corneal endothelial cells with varying degrees of success. Different strategies have also been developed for injecting and delivering these cells into the human eye. This review aims to compile the information published on the latest advances in endothelial disease therapy.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →